Attached files

file filename
EX-10.78 - FORM OF NON-STATUTORY STOCK OPTION AGREEMENT - HEAT BIOLOGICS, INC.htbx_ex10z78.htm
EX-32.1 - CERTIFICATION PRINCIPAL EXECUTIVE OFFICER - HEAT BIOLOGICS, INC.htbx_ex32z1.htm
EX-32.2 - CERTIFICATION PRINCIPAL FINANCIAL OFFICER - HEAT BIOLOGICS, INC.htbx_ex32z2.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - HEAT BIOLOGICS, INC.htbx_ex31z2.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - HEAT BIOLOGICS, INC.htbx_ex31z1.htm
EX-21.1 - SUBSIDIARIES - HEAT BIOLOGICS, INC.htbx_ex21z1.htm
EX-10.79 - FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT - HEAT BIOLOGICS, INC.htbx_ex10z79.htm
EX-10.77 - FORM OF INCENTIVE STOCK OPTION AGREEMENT - HEAT BIOLOGICS, INC.htbx_ex10z77.htm
10-K - ANNUAL REPORT - HEAT BIOLOGICS, INC.htbx_10k.htm

 


EXHIBIT 23.1


Consent of Independent Registered Public Accounting Firm


Heat Biologics, Inc.

Durham, North Carolina


We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-214868, and No. 333-221201) and Form S-8 (No. 333-193453, No. 333-196763, No. 333-207108, No. 333-213133 and No. 333-219238) of Heat Biologics, Inc. of our report dated March 2, 2018, relating to the consolidated financial statements, which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.


/s/ BDO USA, LLP


BDO USA, LLP

Raleigh, NC

March 2, 2018